Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Yusuf, Salim; Bosch, Jackie; R. Dagenais, Gilles; Zhu, Jun; Xavier, Denis; Liu, Lisheng; Pais, Prem; López‐Jaramillo, Patricio; A. Leiter, Lawrence; Dans, Antonio; Avezum, Álvaro; Soares Piegas, Leopoldo; Parkhomenko, Alexander; Keltai, Katalin; Keltai, Mátyás; Sliwa, Karen; J.G. Peters, Ron; Held, Claes; Е Чазова, И; Yusoff, Khalid; S. Lewis, Basil; Janský, Petr; Khunti, Kamlesh; D. Toff, William; M. Reid, Christopher; Varigos, George; Sanchez-Vallejo, Gregorio; S. McKelvie, Robert; Pogue, Janice; Jung, Hyejung; Gao, Peggy; Díaz, Rafael; Lonn, Eva

doi:10.1056/nejmoa1600176

Public

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Published in New England Journal of Medicine • Apr 2, 2016

Authors:

Salim Yusuf

Jackie Bosch

Gilles R. Dagenais

Abstract

BACKGROUND: Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inflammatory markers and involved mainly white persons. It is u...

Subject

Medicine

Rosuvastatin

Hazard ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!